-+ 0.00%
-+ 0.00%
-+ 0.00%

United Therapeutics Chairperson and CEO Martine A. Rothblatt reports disposal of common shares worth $5,031,247.39

PUBT·08/24/2026 20:31:40
Listen to the news
United Therapeutics Chairperson and CEO Martine A. Rothblatt reports disposal of common shares worth $5,031,247.39
  • United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares at USD 135.42 on Aug. 21, 2026.
  • The trust then sold 9,500 shares in the market at weighted-average prices from USD 512.71 to USD 527.71.
  • Trust holdings fell to 324,443 shares following the transactions.
  • The filing also reported 40,513 shares held directly.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-26-000126), on August 24, 2026, and is solely responsible for the information contained therein.